By Patricia Weiss BERLIN, Jan 13 (Reuters) - The pharmaceuticals and agriculture group Bayer aims to return its pharmaceuticals business to mid-single-digit percentage growth by no later than 2027 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results